Primary Prevention Strategies for HIV-related Cardiovascular Disease

Sponsored by The Academy for Continued Healthcare Learning (ACHL).

This activity is supported by an educational grant from Gilead Sciences, Inc.

Scroll to the Bottom of this Information to Begin this Course

Release date: May 31, 2017

Valid through: May 31, 2018

Specialty: Cardiology, Infectious Disease

Topic: HIV-related Cardiovascular Disease

Media: Internet

Estimated Time to Complete Activity: 30 minutes

Target Audience

This educational activity is designed for cardiologists, infectious disease specialists, primary care physicians, and other clinicians interested in the management of patients with HIV-related cardiovascular disease (CVD).

Program Overview

This text-based eNewsletter is the final in a four-part series. It reviews modification of traditional CVD risk factors in HIV-infected individuals with a focus on primary prevention and statin therapy. Short audio commentary provided by Dr. Merle Myerson compliments text and provides practical information.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify the most appropriate statins for patients with HIV and CVD risk factors based on their current ART
  • Discuss the high rates of smoking, obesity, diabetes, and hypertension in the HIV population and opportunities to manage these conditions with medication and lifestyle changes

Credit Available

  • Physicians — maximum of 0.5 AMA PRA Category 1 Credit

All other healthcare professionals completing this course will be issued a statement of participation.


Merle Myerson, MD, EdD, FACC, FNLA

Attending Cardiologist
Basset Medical Center
Cooperstown, NY
Attending Cardiologist
Columbia University
New York, NY

Physician Continuing Medical Education

Accreditation Statement

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The Academy for Continued Healthcare Learning designates this enduring material or a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

ACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

Merle Myerson, MD, EdD, FACC, FNLA (Faculty):
Consultant: Amgen, Inc., Gilead Sciences, Inc., Regeneron Pharmaceuticals, Inc.

The faculty will not be discussing the use of any unlabeled/unapproved drugs or devices.

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Instructions for Participation and Credit

This activity will take approximately 30 minutes to complete. To receive credit, participants are required to complete the pre-test, view the e-newsletter and complete the post-test and evaluation. To receive credit, 66% must be achieved on the post-test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions about this activity, please contact Laurie Novoryta at

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.


The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products.

This series consists of 4 continuing education eNewsletters to launch quarterly starting September 2016. View series activity titles and launch dates here.